PFE

Pfizer Inc

29.44

Oct 19 • 3:59 PM ET -0.14 (-0.47%)

29.42

Aftermarket • 7:59 PM ET -0.02 (-0.07%)

Healthcare Drug Manufacturers - General USA Large NYSE

Peers: GSK AZN BMY MRK SNY NVS ABBV JNJ AMGN LLY

| Held by: VTI VOO IVV SPY VTV XLV HDV HDV VYM DVY

Index	S&P 500
Market Cap	167.80B
Enterprise Value	219.60B
Income	4.33B
Sales	63.70B
Book/sh	14.95
Cash/sh	2.05
Dividend Est.	1.72 (5.85%)
Dividend TTM	1.72 (5.84%)
Dividend Ex-Date	Nov 06, 2026
Dividend Gr. 3/5Y	2.23% 2.37%
Payout	126.85%
Employees	75000
IPO	Jan 17, 1944

P/E	38.98
Forward P/E	10.16
PEG	-
P/S	2.63
P/B	1.97
P/C	14.34
P/FCF	15.27
EV/EBITDA	9.34
EV/Sales	3.45
Quick Ratio	0.96
Current Ratio	1.27
Debt/Eq	0.74
LT Debt/Eq	0.71
Option/Short	Yes / Yes

EPS (ttm)	0.76
EPS next Y	2.90
EPS next Q	0.73
EPS this Y	-8.07%
EPS next Y	-2.08%
EPS next 5Y	-8.26%
EPS past 3/5Y	-37.19% -3.57%
Sales past 3/5Y	-14.56% 8.48%
EPS Y/Y TTM	-59.71%
Sales Y/Y TTM	-0.21%
EPS Q/Q	-108.60%
Sales Q/Q	2.60%
Earnings	Nov 03 BMO
EPS/Sales Surpr.	12.87% 4.41%

Insider Own	0.09%
Insider Trans	2.18%
Inst Own	69.71%
Inst Trans	-0.48%
ROA	2.13%
ROE	4.99%
ROIC	2.97%
Gross Margin	64.83%
Oper. Margin	26.57%
Profit Margin	6.80%
SMA20	3.57%
SMA50	5.06%
SMA200	10.73%
Trades

Shs Outstand	5.70B
Shs Float	5.69B
Short Float	2.64%
Short Ratio	4.28
Short Interest	150.22M
52W High	29.88 -1.47%
52W Low	23.62 24.64%
Volatility	1.83% 1.85%
ATR (14)	0.54
RSI (14)	66.91
Beta	0.27
Rel Volume	0.59
Avg Volume	35.07M
Volume	20,816,659

Perf Week	3.66%
Perf Month	6.44%
Perf Quarter	18.04%
Perf Half Y	6.98%
Perf YTD	18.23%
Perf Year	20.11%
Perf 3Y	-5.61%
Perf 5Y	-30.05%
Perf 10Y	-4.71%
Recom	2.62
Target Price	28.99
Prev Close	29.58
Price	29.44
Change %	-0.47%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-06-26	Downgrade	HSBC Securities	Buy → Hold	$28
Jun-10-26	Upgrade	RBC Capital Mkts	Underperform → Sector Perform	$25
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39

Show Previous Ratings

Oct-17-26 12:15PM	Pfizer or Kraft Heinz: Only One Gets My Dividend Dollars for the Next 10 Years (TIKR)
Oct-16-26 10:57PM	What Was Eli Lilly Telling You Before Its Stock Ran? (Trefis)
08:53PM	When Amgen's Forecast And Chart Say The Same Thing, Pay Attention (Trefis)
08:37PM	Gileads HIV Prevention Business Just Topped $1 Billion A Quarter. What Comes Next? (Trefis)
08:13PM	Is Amgen Stock Increasing Your Market Risk? (Trefis)
10:44AM	Loading…
10:44AM	What Is The Case For Waiting On Moderna Stock? (Trefis)
Oct-15-26 03:59PM	Better Dividend Stock: Pfizer vs. GSK (TIKR)
03:46PM	How Has Merck's Story Changed? (Trefis)
09:09AM	Where Could Johnson & Johnson's Next Growth Come From? (Trefis)
05:30AM	Big Pharma Is Pouring Billions Into a New Class of 'Protein Degrader' Drugs (The Wall Street Journal)
Oct-14-26 11:47PM	Why Did GME, BMBL, PFE Stocks Hit 52-Week Highs Today? (Stocktwits)
09:47PM	How Much Downside Is Left In Liquidia Stock? (Trefis)
05:45PM	What Could Send Regeneron Stock Higher? (Trefis)
03:34PM	Better High-Yield Dividend Stock: Pfizer vs. General Mills (TIKR)
03:25PM	Better High-Yield Dividend Stock: Pfizer vs. British American Tobacco (TIKR)
03:12PM	Loading…
03:12PM	Better High-Yield Dividend Stock: Pfizer vs. UPS (TIKR)
03:01PM	Better High-Yield Dividend Stock: Pfizer vs. Healthpeak (TIKR)
02:40PM	Better High-Yield Dividend Stock: Pfizer vs. Edison International (TIKR)
02:34PM	Better High-Yield Dividend Stock: Pfizer vs. Clorox (TIKR)
09:31AM	J&J earnings set negative tone; Shkreli vs. the FTC (BioPharma Dive)
08:18AM	The Open Question Under Johnson & Johnson Stock's Price (Trefis)
06:45AM	Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026 (Business Wire)
06:39AM	Pfizer partners with Enodia Therapeutics in $500m drug deal (Pharmaceutical Business Review)
Oct-13-26 07:48PM	Is Amgen Stock Worth More Than Its Competitors? (Trefis)
04:20PM	Pfizer or Enbridge: Only One Gets My Dividend Dollars for the Next 10 Years (TIKR)
03:59PM	What Does Bristol-Myers Squibb Offer That Pfizer Does Not? (Trefis)
03:24PM	What Is Eli Lilly Stock's Biggest Opportunity? (Trefis)
03:00AM	Ozempic face powers revival of a fading British giant (The Telegraph)
Oct-12-26 05:01PM	Where Could Moderna's Next Growth Come From? (Trefis)
10:15AM	Bristol Myers Stock Is Rising on a Double Dose of Good News (Barrons.com)
09:22PM	Loading…
Oct-11-26 09:22PM	SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH (Stocktwits)
Oct-10-26 12:06PM	Four Analysts Raised Their Pfizer Targets in One Week Without an Upgrade. Heres Where the Stock Could Go By 2030 (TIKR)
Oct-09-26 08:47PM	Why Is Everyone Ignoring Gilead Stock's High Cash Yield? (Trefis)
08:09PM	BNTX, NVAX, MRNA Lead Vaccine Rally After Report Of An NIH Cancer-Vaccine Push (Stocktwits)
04:13PM	Moderna stock hits 4-year high on planned national cancer vaccine effort (Yahoo Finance)
03:39PM	Top Research Reports for JPMorgan, ASML & Chevron (Zacks)
02:12PM	Does The Move In Merck Stock Change Anything? (Trefis)
12:14PM	Moderna stock jumps on planned national cancer vaccine effort (Yahoo Finance)
11:18AM	FDA review docs spark Revolution sell-off; Zealand diabetes data underwhelm analysts (BioPharma Dive)
Oct-08-26 08:36PM	Should You Be Worried About Pfizer Stock? (Trefis)
08:19PM	What Is Going On With Regeneron Stock? (Trefis)
09:35AM	PFE, LLY, MRK Stocks In Focus: Cantor Raises Price Targets On Pharma Behemoths, But Flags Growth Concerns For Pfizer (Stocktwits)
09:04AM	Medicus Pharma targets partnerships and clinical milestones as oncology pipeline advances (Proactive)
09:03AM	What Would It Take For Amgen Stock To Move Higher? (Trefis)
07:07AM	FDA approves Pfizer's Tukysa regimen for metastatic breast cancer (Pharmaceutical Business Review)
Oct-07-26 07:14PM	Is Exelixis Stock Engineered To Make You Money? (Trefis)
12:57PM	Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer (Business Wire)
12:13PM	Why You Should Think About Eli Lilly Stock Differently Now (Trefis)
Oct-06-26 07:30PM	Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026 (PR Newswire)
04:48PM	Novavax, Moderna stocks fall after WHO calls plague risk 'low' (Yahoo Finance)
10:00AM	Pfizer Declares Fourth-Quarter 2026 Dividend (Business Wire)
08:44AM	Vaxcyte VAX-31 pneumococcal vaccine phase 3 trial results (Quartz)
01:38AM	Pfizers $6.49 Billion Prevnar Franchise Faces a New Challenger (TIKR)
Oct-05-26 02:37PM	PCVX Stock Hits Fresh 52-Week High On Late-Stage Win In Adult Pneumonia Vaccine Race: Jefferies Says It Hit Blue-Sky Case (Stocktwits)
02:18PM	Drug stocks show rare weakness amid fears of vaccine competition (MarketWatch)
10:43AM	Vaxcyte Soars 36% on Phase 3 Pneumococcal Vaccine Win That Sets a New Benchmark (TIKR)
10:39AM	Vaxcytes stock up after pneumococcal vaccine proves non-inferiority (Clinical Trials Arena)
10:32AM	Vaxcyte shares surge on late-stage vaccine trial success (Proactive)
10:23AM	Vaxcyte Stock Spikes 57% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck (Barrons.com)
10:19AM	Has Eli Lilly Stock Peaked? (Trefis)
10:01AM	Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study (Investor's Business Daily)
09:52AM	Vaxcyte skyrockets on near best-case pneumococcal vaccine data (BioPharma Dive)
07:57AM	EADV26: Key late-stage readouts from the conference (Clinical Trials Arena)
Oct-02-26 11:37AM	Pfizers Eczema Drug Hit a 61% Response Rate the Day Florida Sued. Heres What It Means for the Stock (TIKR)
11:15AM	Pfizer's LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo (Business Wire)
06:27AM	How Has Pfizer's Story Changed? (Trefis)
Oct-01-26 01:09PM	Pfizer Scores Promising Win for Experimental Eczema Drug (GuruFocus.com)
11:41AM	What Is The Options Market Telling Us About Eli Lilly Stock? (Trefis)
02:30AM	Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study (Business Wire)
Sep-30-26 03:01PM	Was The Run In JNJ Stock Hiding In Plain Sight? (Trefis)
12:19PM	Invivyds Covid-directed mAb hits Phase III safety goals (Clinical Trials Arena)
11:34AM	PFE vs. BMY: Each Faces a $22 Billion+ Patent Cliff. One Dividend Looks Much Safer (TIKR)
11:29AM	Are You Overpaying For Pfizer Stock Versus Its Rivals? (Trefis)
10:43AM	What Is Merck Stock's Biggest Opportunity? (Trefis)
Sep-29-26 04:59PM	AstraZeneca Digs $2 Billion Out Of Its Coffers For Summit Deal, Taking On Bristol, Pfizer, Merck (Investor's Business Daily)
02:43PM	Is Eli Lilly Stock a Good Fit For Your Portfolio Risk? (Trefis)
12:23PM	Management Raised the Bar For Eli Lilly Stock; Does The Chart Agree? (Trefis)
Sep-28-26 04:33PM	$85 Billion And Counting: JNJ Stock's Steady Cash-Return Habit (Trefis)
02:08PM	What Are Merck Stock Investors Overlooking? (Trefis)
10:06AM	BioNTech to Close Manufacturing Sites in Germany and Singapore After Sale Process Ends (InvestorsHub)
08:50AM	What Bavarian Nordics next CEO is up against (Pharma Voice)
06:45AM	Pfizer Advances Today's Cancer Care and Tomorrow's Potential Breakthroughs at ESMO (Business Wire)
Sep-27-26 08:46AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
Sep-25-26 01:13PM	Is LLY Stock Cheaper Than It Looks? (Trefis)
01:03PM	Pfizer Stock Paid Out $49B: So Why Did Investors Lose Money? (Trefis)
11:39AM	Innovation Is Driving a New Bull Market in Biotech. 16 Ways to Play It, From Our Roundtable Experts. (Barrons.com)
Sep-24-26 03:03PM	Can Eli Lilly Stock Catch Up To Rivals It Outgrows? (Trefis)
Sep-23-26 01:18PM	What Is AbbVie No Longer Telling You? (Trefis)
12:53PM	Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker Is Going Next (Barrons.com)
12:37PM	What Is The Best Case For Pfizer Stock? (Trefis)
10:39AM	Pfizers International Chief Just Explained How the Turnaround Actually Works. Heres Where the Stock Could Go (TIKR)
Sep-22-26 01:39PM	Was Moderna Stock's Cancer Vaccine Run Visible In Advance? (Trefis)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts (Business Wire)
09:50AM	Could You Have Seen Merck Stock's Pipeline Run Coming? (Trefis)
09:40AM	Why Is JNJ Stock Beating Rivals That Grow Faster? (Trefis)
Sep-21-26 12:43PM	NYC Office-to-Residential Conversions Keep Gaining Steam (CRE Daily)
10:40AM	Huge News For Pfizer Stock Fans (GuruFocus.com)
10:17AM	What Would It Take For Pfizer To Cut Its Dividend? (Trefis)
Sep-19-26 05:12PM	Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices (Bloomberg)
Sep-18-26 05:23PM	What Would It Take For Eli Lilly Stock To Keep Climbing? (Trefis)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Ph.D.Dr. Albert Bourla D.V.M.

M.D.Dr. Chris Boshoff FMedSci

Executive VP & Chief Legal OfficerMr. Douglas M. Lankler

Executive VP & Chief U.S. Commercial OfficerMr. Aamir Malik

Interim CFO & Executive VPMs. Cecile Guegan

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Aug 12 '26	Buy	26.34	38,000	1,000,920	429,173	Aug 12 04:04 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 05 '26	Sale	25.40	3,278	83,261	28,611	Aug 06 11:26 AM
BLAYLOCK RONALD E	Director	Aug 05 '26	Buy	25.46	39,231	998,821	66,938	Aug 05 04:03 PM
Buckley Mortimer J	Director	Aug 05 '26	Buy	25.52	37,632	960,369	37,632	Aug 05 04:02 PM
DAMICO JENNIFER B.	SVP & Controller	Jun 09 '26	Sale	25.70	2,000	51,400	31,397	Jun 10 07:58 PM
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM

Open in Screener

KMX

Carmax Inc

51.65

Oct 19 • 3:59 PM ET -1.68 (-3.15%)

51.65

Aftermarket • 7:30 PM ET 0.00 (0.00%)

Consumer Cyclical Auto & Truck Dealerships USA Mid NYSE

Peers: CVNA AN LAD GPI PAG SAH OPLN CARG LKQ AZO

| Held by: IJR VTI VB AVUV DFSV VBR VXF SPSM IJS DFAS

Index	-
Market Cap	7.33B
Enterprise Value	24.63B
Income	292.44M
Sales	29.44B
Book/sh	44.42
Cash/sh	5.46
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	27796
IPO	Feb 04, 1997

P/E	25.29
Forward P/E	-
PEG	-
P/S	0.25
P/B	1.16
P/C	9.45
P/FCF	6.40
EV/EBITDA	23.87
EV/Sales	0.84
Quick Ratio	0.57
Current Ratio	2.33
Debt/Eq	2.87
LT Debt/Eq	2.76
Option/Short	Yes / Yes

EPS (ttm)	2.04
EPS next Y	-
EPS next Q	0.43
EPS this Y	9.57%
EPS next Y	-
EPS next 5Y	13.22%
EPS past 3/5Y	-17.96% -18.02%
Sales past 3/5Y	-3.76% 6.67%
EPS Y/Y TTM	-40.01%
Sales Y/Y TTM	4.09%
EPS Q/Q	82.04%
Sales Q/Q	17.64%
Earnings	Sep 29 BMO
EPS/Sales Surpr.	58.41% 11.09%

Insider Own	2.04%
Insider Trans	0.84%
Inst Own	102.96%
Inst Trans	-5.69%
ROA	1.10%
ROE	4.68%
ROIC	1.23%
Gross Margin	10.53%
Oper. Margin	2.19%
Profit Margin	0.99%
SMA20	-5.08%
SMA50	-11.07%
SMA200	5.56%
Trades

Shs Outstand	141.93M
Shs Float	139.05M
Short Float	7.74%
Short Ratio	4.14
Short Interest	10.76M
52W High	65.28 -20.88%
52W Low	30.26 70.69%
Volatility	3.61% 4.45%
ATR (14)	2.29
RSI (14)	39.33
Beta	1.22
Rel Volume	0.95
Avg Volume	2.60M
Volume	2,465,684

Perf Week	1.89%
Perf Month	-9.72%
Perf Quarter	-10.35%
Perf Half Y	27.03%
Perf YTD	33.67%
Perf Year	20.40%
Perf 3Y	-18.56%
Perf 5Y	-62.71%
Perf 10Y	-0.21%
Recom	2.64
Target Price	61.08
Prev Close	53.33
Price	51.65
Change %	-3.15%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-15-26	Upgrade	BofA Securities	Underperform → Buy	$65
Jul-29-26	Upgrade	JP Morgan	Underweight → Neutral	$60
Jul-21-26	Upgrade	Barclays	Underweight → Equal Weight	$61
Jun-18-26	Upgrade	Stephens	Equal-Weight → Overweight	$66
May-27-26	Initiated	UBS	Neutral	$42
Apr-15-26	Resumed	BofA Securities	Underperform	$40
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75

Show Previous Ratings

Oct-15-26 12:48PM	CarMax upgraded to 'buy' by Bank of America as pricing gains drive market share (Proactive) +5.62%
09:39AM	CarMax upgraded, Spotify downgraded: Wall Street's top analyst calls (The Fly)
08:38AM	Penske Automotive Is Going Private. The Stock Is Rising. (Barrons.com)
08:22AM	CarMax stock climbs after BofA upgrades to Buy on improving outlook (Investing.com)
Oct-09-26 07:46PM	Is There A Risk Hiding In Carvana Stock's Record Quarter? (Trefis)
09:27PM	Loading…
Oct-08-26 09:27PM	Two Reasons To Stay Away From Carvana Stock (Trefis)
Oct-06-26 12:56PM	25 Stocks to Avoid as October Trading Gets Underway (Schaeffer's Research)
Oct-05-26 10:45AM	CarMax sales surge, buoyed by cost-cutting (Wards Auto)
Oct-02-26 10:20AM	Carvana Stock Is the 'Best Story' in Autos. One Thing Could Slow It Down. (Barrons.com)
Sep-30-26 08:10PM	Earnings Calendar and Analysis for This Week (Kiplinger) -6.96%
05:00PM	CarMax to Host Strategic Update Webcast on November 3, 2026 (Business Wire)
08:30AM	Carvana Stock Jumped 5% in a Day as Jefferies Tracked 40% Unit Growth. Heres Where Shares Could Go by 2030 (TIKR)
Sep-29-26 09:00PM	CarMax Inc (KMX) (Q2 2027) Earnings Call Highlights: 81% EPS Surge, 13% Used Unit Comps and the ... (GuruFocus.com)
01:08PM	FTC Crackdown on Misleading Car Ads Buoys CarMax, CEO Says (The Wall Street Journal)
09:33AM	Pre-Markets Rebound Moderately After Monday's Selloff (Zacks)
09:00AM	Loading…
09:00AM	CarMax's profit surged 81% as a pricing push drove used-vehicle sales higher (Quartz)
08:53AM	CarMax Q2 FY2027 earnings beat on used-vehicle sales jump (Quartz)
08:37AM	CarMax earnings surge as used vehicle sales jump (Proactive)
07:45AM	CarMax Shares Rise as Q2 Earnings and Revenue Exceed Forecasts (InvestorsHub)
07:39AM	Premarket movers: FICO sinks while Summit, AAR and CarMax rise (Investing.com)
06:57AM	CarMax Posts Higher Profit as Vehicle Sales Rise (The Wall Street Journal)
06:43AM	CarMax shares rise over 2% on strong earnings and revenue beat (Investing.com)
06:34AM	CarMax Stock Rises on Earnings Beat. There's 1 Big Sign the Turnaround Is Working. (Barrons.com)
06:00AM	CarMax Announces Leadership Appointments to Further Unify End-to-End Customer Experience, Advance Strategy for Growth (Business Wire)
05:57AM	CarMax: Fiscal Q2 Earnings Snapshot (Associated Press)
05:50AM	CarMax Reports Second Quarter Fiscal 2027 Results (Business Wire)
04:32AM	Carnival headlines Tuesday's earnings slate (MarketWatch)
04:31AM	Nasdaq Futures Tread Water After Monday Rout: MU, NVTS, NVO, KOD, SMMT, ASTS Stocks In Focus (Stocktwits)
Sep-27-26 05:00AM	What to Expect in Markets This Week: Latest US Inflation, Jobs Data; Micron, CarMax Report (Investopedia)
Sep-24-26 12:44PM	The Week Ahead: Employment Report, PMI Data Kick Off October (Schaeffer's Research)
07:41AM	Loading…
Sep-22-26 07:41AM	CarMax layoffs: 145 corporate jobs cut for third time in a year (Quartz)
Sep-21-26 06:30PM	KMX Stock Edges Higher: CarMax Shares Bounce As 145 Corporate Jobs Go Ahead Of Q2 Report (Stocktwits)
02:28PM	CarMax Cuts Jobs for Third Time in 12 Months Amid Soft Auto Market (The Wall Street Journal)
Sep-18-26 01:16PM	Should You Buy Copart Stock On The ACV Deal? (Trefis)
Sep-09-26 05:00PM	CarMax Announces Second Quarter Conference Call (Business Wire)
Aug-27-26 01:31AM	No AI, No Problem: 5 Consumer Stocks Quietly Outperforming Nvidia This Year (Stocktwits)
Aug-25-26 08:30AM	Gen Alpha Turns 16: New CarMax Survey Reveals the Next Generation of Drivers Is Ready to Get Behind the Wheel (GlobeNewswire)
Aug-12-26 09:45AM	CarMax Named one of the 2026 PEOPLE Companies That Care (GlobeNewswire)
Aug-06-26 09:36PM	The Takeover Case for OPLN: A Digital Powerhouse Hiding in Plain Sight (Trefis)
09:30AM	CarMax Teams with Sierra to Enhance Inbound Sales Call Experience (GlobeNewswire)
Aug-05-26 12:23PM	Starboard Value Has Taken New Position in Shake Shack (Bloomberg)
Jul-29-26 05:16PM	JPMorgan Delivers Major CarMax Stock Reset (GuruFocus.com)
Jul-02-26 12:43PM	CarMax's Turnaround Is a Work in Progress, but Insiders Are Buying Anyway (Barrons.com)
Jun-30-26 10:00AM	CarMax Recognized as One of the 50 Most Community-Minded Companies in the US (GlobeNewswire)
Jun-26-26 07:00AM	For CarMax, lower profits are part of its short-term growth strategy (Wards Auto)
Jun-18-26 06:54PM	The Price Of A CarMax Sales Beat (Trefis) +13.14%
01:29PM	KMX Stock Recoups Earnings Day Losses Analysts Pour Praise On New CarMax CEOs Focus On Cost And Customer Experience (Stocktwits)
09:02AM	CarMax Q1 FY2027 earnings beat: Keith Barr unveils growth strategy (Quartz)
09:02AM	CarMax beat earnings estimates but is facing falling used-car margins as new CEO unveils growth strategy (Quartz)
Jun-17-26 04:43PM	CarMax Earnings Fall Far Less Than Feared, But Shares Sink (Investor's Business Daily) -8.98%
03:01PM	KMX Stock Slides Nearly 9% CarMax CEO Flags Operational Challenges, Says Costs Are Too High (Stocktwits)
03:00PM	CarMax Inc (KMX) Q1 2027 Earnings Call Highlights: Strong Sales Growth Amidst Profitability ... (GuruFocus.com)
11:09AM	?? Under the Radar: CarMax Stock Slides as CEO Flags Challenges (The Wall Street Journal)
10:34AM	CarMax shares drop as margin pressure overshadows strong quarterly results (Proactive)
10:12AM	Options Traders Circle CarMax Stock After Post-Earnings Pivot (Schaeffer's Research)
08:45AM	CarMax Tops Expectations as Growth Plan Gains Momentum (KMX) (InvestorsHub)
06:48AM	CarMax beats estimates as new strategy drives early results (Investing.com)
06:38AM	CarMax Profit Falls Despite Higher Sales (The Wall Street Journal)
06:37AM	CarMax Stock Rises. Used-Car Retailer Tops Earnings Estimates. (Barrons.com)
06:05AM	CarMax: Fiscal Q1 Earnings Snapshot (Associated Press)
05:50AM	CarMax Reports First Quarter Fiscal 2027 Results (Business Wire)
Jun-14-26 02:00PM	The FOMC Meeting, Retail Sales Data, Kroger Earnings, and More to Watch This Week (Barrons.com)
May-28-26 05:00PM	CarMax Announces First Quarter Conference Call and Annual Meeting Information (Business Wire)
May-27-26 09:35AM	FedEx upgraded, Dollar General downgraded: Wall Street's top analyst calls (The Fly)
May-12-26 04:40PM	CarMax Announces Robert O'Shaughnessy to Join Board of Directors (Business Wire)
May-08-26 10:43AM	Will Carvana Continue To Rally Post Stock Split? (Trefis)
Apr-17-26 08:13AM	CarMax prices start to fall as turnaround plan begins (Wards Auto)
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	CarMax cut its prices to bring back buyers. It just reported a $121 million loss (Moneywise)
03:01AM	CarMax Inc (KMX) Q4 2026 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
Apr-14-26 04:46PM	CarMax, Inc. Q4 2026 Earnings Call Summary (Moby) -15.12%
02:10PM	Tesla stock upgraded, CarMax Q4 earnings disappoint Wall Street (Yahoo Finance Video)
01:23PM	Why CarMax Stock Is Sinking Despite Earnings Beat (Investor's Business Daily)
12:44PM	CarMax Shares Drop 12% As Profit Per Vehicle Set To Decline (GuruFocus.com)
11:11AM	CarMax Drops as Investors Underwhelmed by Revival Strategy (Bloomberg)
07:32AM	CarMax beats FQ4 forecasts, flags $141mn goodwill charge; shares dip (Investing.com)
07:23AM	CarMax Swings to Loss After Cutting Prices to Bring Back Shoppers (The Wall Street Journal)
07:09AM	CarMax: Fiscal Q4 Earnings Snapshot (Associated Press)
07:04AM	CarMax Stock Sinks After Earnings. New CEO Has Work to Do. (Barrons.com)
06:50AM	CarMax Reports Fourth Quarter and Fiscal Year 2026 Results (Business Wire)
06:00AM	Morning Brief: Goldman rakes it in, but issues a warning (Yahoo Finance)
04:57AM	JPMorgan, Citi and Wells Fargo deliver results as earnings season gathers speed (MarketWatch)
04:11AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to hold near record highs as earnings season ramps up with JPMorgan results on tap (MarketWatch)
Apr-09-26 04:51PM	CarMax Will Add Two Board Members After Talks With Activist Investor Starboard (The Wall Street Journal)
04:15PM	CarMax Announces William Cobb and Jim Kessler to Join the Board (Business Wire)
Apr-06-26 11:16AM	Carvana Stock Doubled Last Year. Why This Analyst Isn't Bullish Anymore. (Barrons.com)
Apr-01-26 09:30AM	CARMAX CELEBRATES 22nd CONSECUTIVE YEAR AS ONE OF FORTUNE MAGAZINE'S 100 BEST COMPANIES TO WORK FOR (GlobeNewswire)
Mar-27-26 07:15AM	New CarMax CEO Barr looks to tech for better UX (Wards Auto)
Mar-26-26 04:37PM	Stock traders are wary of this market - and retail investors should be too (MarketWatch)
Mar-19-26 05:00PM	CarMax Announces Fourth Quarter Conference Call (Business Wire)
04:12PM	These charts suggest the bears aren't done with the stock market yet (MarketWatch)
Mar-18-26 11:45AM	CarMax appoints Keith Barr as CEO (Wards Auto)
Mar-13-26 08:44PM	Oracle Has More Resilience Amid AI Pressures, Says Analyst. Plus, CarMax, Rivian, and More Stocks. (Barrons.com)
Mar-12-26 06:40PM	The S&P 500 just broke a major support. Another 10% decline is likely. (MarketWatch)
Mar-11-26 04:20PM	Investor Starboard Sees CarMax Upside as Barr Takes Helm (Transport Topics)
02:30PM	Starboard Builds $350 Million Stake in CarMax, Seeks Board Seats (GuruFocus.com)
01:40PM	Starboard Takes $350 Million CarMax Stake, Seeks Board Seats (Bloomberg)
01:01PM	An Important Investor Has an Idea for CarMax: Charge Less for Used Cars (Investopedia)
11:29AM	Falling prices steer US buyers toward used electric vehicles (Reuters)
10:35AM	CarMax Issues Statement on Engagement With Starboard Value (Business Wire)

CarMax, Inc.is a holding company, which engages in the retail sale of used vehicles and wholesale vehicle sales. It operates through the following segments: CarMax Sales Operations, and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of retail sales of used vehicles, wholesale vehicle sales, related products and services, vehicle repair services, and financing arrangements. The CAF segment consists of its finance operation, which provides financing to customers purchasing retail vehicles from CarMax. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Executive VPMr. Enrique N. Mayor-Mora

Executive VP & COOMr. Charles Joseph Wilson

Executive VP and Chief Information & Technology OfficerMr. Shamim Mohammad CPA

Executive VPMs. Diane Long Cafritz J.D.

CEOMr. Keith Barr

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chawla Sona	Director	Jun 25 '26	Buy	53.39	2,000	106,780	21,702	Jun 26 04:13 PM
Shinder Marcella	Director	Jun 25 '26	Buy	52.01	574	29,854	24,993	Jun 26 04:13 PM
ONeil Mark F	Director	Jun 24 '26	Buy	52.36	4,800	251,328	4,800	Jun 26 04:13 PM
ONeil Mark F	Director	Jun 24 '26	Buy	52.36	4,800	251,328	29,490	Jun 26 04:13 PM
FOLLIARD THOMAS J	Director	Jun 23 '26	Option Exercise	51.91	14,855	771,123	227,676	Jun 24 05:21 PM
Bensen Peter J	Director	Jun 22 '26	Buy	52.20	2,500	130,500	24,796	Jun 24 05:21 PM
Barr Keith	President and CEO	Jun 22 '26	Buy	53.01	9,400	498,247	33,375	Jun 24 05:20 PM
McCreight David W.	Director	Mar 16 '26	Option Exercise	41.71	30,558	1,274,574	47,257	Mar 18 04:11 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your Finviz experience